Andrew D. Ashe

Filings by Andrew D. Ashe span 2 companies, the busiest being Dyax Corp and Verve Therapeutics, Inc. Over a trading history stretching from 14 January 2016 to 25 July 2025, the count stands at 14 filings.

No open-market sale appears; the market trades are 2 purchases worth €553k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 10 option exercises.

The record was last updated on 28 July 2025 with a transaction in Verve Therapeutics, Inc. The clock since the last published purchase (15 May 2024) now reads 886 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.